JP Morgan Cazenove Maintains Overweight Rating on Hiscox (HCXLF)

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Nov 08 2025

0mins

Source: NASDAQ.COM

Analyst Recommendation: JP Morgan Cazenove has reiterated an Overweight recommendation for Hiscox, projecting a 15.80% upside with an average one-year price target of $16.15/share.
Revenue and EPS Projections: Hiscox's projected annual revenue is $5,413 million, reflecting a 37.85% increase, with a projected non-GAAP EPS of 1.62.
Fund Sentiment: There are 175 funds reporting positions in Hiscox, with a slight increase in ownership, although total shares owned by institutions decreased by 4.36% in the last three months.
Shareholder Activity: Various funds have adjusted their holdings in Hiscox, with some increasing their portfolio allocation while others, like John Hancock Disciplined Value International Fund, significantly decreased their shares.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.